Yohanan Engelhardt Net Worth

Yohanan Engelhardt biography

Yohanan Engelhardt is Director of the Company. Mr. Engelhardt provides CFO-consulting and accounting services to early-stage technology and medical device companies and to an accounting firm, including oversight and advice on strategic planning, business plans, financial projections and analysis, GAAP financial statements, accounting and costing, private placements, stock compensation plans and strategies, cash management, risk and audit management, taxation, investments, mergers and acquisitions and ownership transition strategies. From 1996-2014 Mr. Engelhardt served as the Chief Financial Officer and VP of Finance of ViryaNet, a publicly-traded company, in which he oversaw all financial operations including SEC reporting, planning and forecasting, audits, business analysis, accounting, tax, treasury, strategic planning and SOX compliance, and managed all financial and capital structure functions, including equity, bank debts, and receivables financing.

How old is Yohanan Engelhardt?

Yohanan Engelhardt is 56, he's been the Director of Rewalk Robotics Ltd since 2018. There are 8 older and 6 younger executives at Rewalk Robotics Ltd. The oldest executive at Rewalk Robotics Ltd is Ami Kraft, 78, who is the Exec. Advisor to the CEO.

What's Yohanan Engelhardt's mailing address?

Yohanan's mailing address filed with the SEC is C/O REWALK ROBOTICS LTD., 3 HATNUFA ST., P.O. BOX 161, YOKNEAM ILIT L3, , 20692203.

Insiders trading at Rewalk Robotics Ltd

Over the last 9 years, insiders at Rewalk Robotics Ltd have traded over $7,660,045 worth of Rewalk Robotics Ltd stock and bought 8,170,475 units worth $6,701,652 . The most active insiders traders include Global Fund Ii Lp Lind Glob..., Glenn P Muir, and Wayne Weisman. On average, Rewalk Robotics Ltd executives and independent directors trade stock every 26 days with the average trade being worth of $88,081. The most recent stock trade was executed by Global Fund Ii Lp Lind on 17 November 2023, trading 54,917 units of RWLK stock currently worth $40,089.

What does Rewalk Robotics Ltd do?

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the

Rewalk Robotics Ltd executives and stock owners

Rewalk Robotics Ltd executives and other stock owners filed with the SEC include:

• Lawrence Jasinski,
  Chief Executive Officer, Director
• Lawrence J. Jasinski,
  CEO & Director
• Ori Gon,
  CFO & Principal Accounting Officer
• Wayne Weisman,
  Independent Director
• John Poduska,
  Independent Director
• Randel Richner,
  Director
• Yasushi Ichiki,
  Director
• Yohanan Engelhardt,
  Director
• Aryeh Dan,
  Director
• Jeff Dykan,
  Independent Chairman of the Board
• Jodi Gricci,
  Vice President - Global Marketing and Training
• Ofir Koren,
  Vice President - Research & Development
• Ori Gon,
  Chief Financial Officer
• Kathleen O'Donnell,
  VP of Marketing & New Bus. Devel.
• Ami Kraft,
  Exec. Advisor to the CEO
• Judy Kula,
  VP of Customer Service, HR & Bus. Affairs
• Andy Dolan,
  VP of Marketing & Reimbursement
• Miri Pariente,
  VP of Operations, Regulatory & Quality
• Peter Wehrly,
  Director
• Kevin Hershberger,
  Chief Financial Officer
• Vitalife Partners (Israel) ...,
  
• Vitalife Partners Ii Lpscp ...,
  
• Vitalife Partners Ii Lpscp ...,
  
• Glenn P Muir,
  Director
• Deborah Di Sanzo Eldracher,
  Director
• Vitalife Partners (Israel) ...,
  
• John Vincent Hamilton,
  VP, Regulatory & Clinical
• Chunlin Han,
  Director
• Vitalife Partners Ii Lpscp ...,
  
• Vitalife Partners (Israel) ...,
  
• Ning Cong,
  
• Global Fund Ii Lp Lind Glob...,
  
• Joseph E Jr Turk,
  Director
• Jeannine Lynch,
  VP of Market Access & Strategy
• Hadar Levy,
  Director
• Almog Adar,
  VP of Finance
• Michael A Lawless,
  Chief Financial Officer
• Global Fund Ii Lp Lind,
  
• Charles Remsberg,
  Chief Sales Officer